News
Apogee Therapeutics said its antibody treatment alleviated signs and symptoms of atopic dermatitis far more than a placebo — ...
As Chinese-developed drugs draw U.S. interest, a regulatory chill threatens to dampen new investment
Those questions, experts say, are based on the Trump administration’s hawkish approach to China generally, as well as on a ...
Ananda Lewis should still be alive. She had access. She had options. What she didn’t have was trust in the system that could ...
WASHINGTON — The steady erosion of experienced staff at the Food and Drug Administration is slowly compromising the agency’s ...
Efforts to eliminate pass-fail grading in medical schools are misguided attempts to undermine the value of a diverse ...
Guidance from the Office of the General Counsel at the Department of Health and Human Services, obtained by STAT, outlines a ...
WASHINGTON — President Trump on Friday signed his landmark tax bill, setting in motion transformational health care ...
Cutting Medicaid will affect all children through a large toll on pediatric health systems,” writes a pediatric ICU physician ...
If we don’t invest in technologies like mRNA vaccines for pandemic influenza now, once a virus starts going human-to-human, ...
Woebot Health this week shut down its core product, a pioneering therapy chatbot. Its demise was hastened by the new wave of ...
We cannot and will not gamble with our patients’ health or the health of our communities,” write the presidents of the AAFP, ...
Proposed cuts will have “a catastrophic effect on the advancement of biomedical and biotechnology capabilities in the United ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results